Replimune Group, Inc. (REPL) Earnings
NASDAQ·Healthcare·Biotechnology
$8.88
+2.96%
Mkt Cap $781.96M
EPS — Estimate vs Actual
Mkt Cap
$781.96M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.58
NASDAQ·Healthcare·Biotechnology
$8.88
+2.96%
Mkt Cap $781.96M
Mkt Cap
$781.96M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.58